Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of CT-guided Ethanol Sympatholysis for Resistant Hypertension
NCT02653222Phase 2Terminated
- Sponsor
- CHU Grenoble Alpes
- Start
- Feb 2016
- Primary completion
- Feb 2018
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in resistant hypertension (RH), sponsored by CHU Grenoble Alpes. Primary endpoint: Success or failure of the peri-arterial technique injection of ethanol under CT guidance at 2 hours. Started Feb 2016; status: terminated.
02
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on NCT02653222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02653222.